首页> 外文期刊>Diabetes technology & therapeutics >Glucose monitoring by means of an intravenous microdialysis catheter technique.
【24h】

Glucose monitoring by means of an intravenous microdialysis catheter technique.

机译:通过静脉微透析导管技术监测血糖。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Patients with acute coronary syndrome (ACS) and hyperglycemia are at an increased mortality risk. A rapidly obtained optimized glycemic control without inducing hypoglycemia is important. We evaluated the accuracy of a microdialysis catheter (CMA 64 IView, CMA Microdialysis AB, Solna, Sweden) to monitor glucose levels in patients in the coronary care unit (CCU). METHODS: Fourteen patients admitted to the CCU with ACS (n = 11) or heart failure (n = 3) had a venous microdialysis catheter applied for 3 days. Glucose levels were measured simultaneously in plasma and microdialysis fluid at eight time points for 1 h each day. RESULTS: The overall congruence between the two measurements of blood glucose was acceptable except in four patients in whom the microdialysis measurements were too low. No obvious relationship between site of the catheter, body composition, blood pressure, diagnosis, or medical treatment and discrepant values was detected. CONCLUSIONS: These initial experiences are promising and motivate further research to improve the microdialysis technique. In future studies longer periods of recordings should be included to disclose technical problems.
机译:背景:患有急性冠状动脉综合征(ACS)和高血糖症的患者死亡风险增加。快速获得优化的血糖控制而不引起低血糖很重要。我们评估了微透析导管(CMA 64 IView,CMA Microdialysis AB,瑞典索尔纳,瑞典)的准确性,以监测冠心病监护病房(CCU)患者的血糖水平。方法:14例因ACS(n = 11)或心力衰竭(n = 3)进入CCU的患者应用了静脉微透析导管3天。每天在八个时间点同时在血浆和微透析液中每天1 h测量葡萄糖水平。结果:两次血糖测量之间的总体一致性是可以接受的,只有四例患者的微透析测量值太低。在导管的部位,身体组成,血压,诊断或医学治疗与差异值之间未发现明显关系。结论:这些初步的经验是有希望的,并激励进一步的研究,以改善微透析技术。在以后的研究中,应包括更长的录音时间以揭示技术问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号